书信: 皮斯塔科西斯

Same author

Glomerulonephritis after human parvovirus infection in homozygous sickle-cell disease.

Lancet (London, England)·1995

Same author

A new parvovirus: similarities between monkeys and humans.

The Journal of clinical investigation·1994

Same author

Human parvovirus B19.

BMJ (Clinical research ed.)·1994

Same author

Human parvovirus infection in homozygous sickle cell disease.

Lancet (London, England)·1993

Same author

Human parvovirus B19 in clotting factor concentrates: B19 DNA detection by the nested polymerase chain reaction.

British journal of haematology·1992

Same author

Prevalence of antibodies against parvovirus B19 in Norwegians with congenital coagulation factor defects treated with plasma products from small donor pools.

Scandinavian journal of infectious diseases·1991

Same journal

Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.

Lancet (London, England)·2026

Same journal

Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.

Lancet (London, England)·2026

Same journal

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Lancet (London, England)·2026

Same journal

Documenting hospice care.

Lancet (London, England)·2026

Same journal

After the wood chipper.

Lancet (London, England)·2026

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

相关实验视频

书信: 皮斯塔科西斯

相关概念视频

Glomerulonephritis after human parvovirus infection in homozygous sickle-cell disease.

A new parvovirus: similarities between monkeys and humans.

Human parvovirus B19.

Human parvovirus infection in homozygous sickle cell disease.

Human parvovirus B19 in clotting factor concentrates: B19 DNA detection by the nested polymerase chain reaction.

Prevalence of antibodies against parvovirus B19 in Norwegians with congenital coagulation factor defects treated with plasma products from small donor pools.

Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.

Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Documenting hospice care.

After the wood chipper.

Assisted dying and the silencing of medicine's next generation.

相关实验视频

书信: 皮斯塔科西斯

相关概念视频

相关文章

Glomerulonephritis after human parvovirus infection in homozygous sickle-cell disease.

A new parvovirus: similarities between monkeys and humans.

Human parvovirus B19.

Human parvovirus infection in homozygous sickle cell disease.

Human parvovirus B19 in clotting factor concentrates: B19 DNA detection by the nested polymerase chain reaction.

Prevalence of antibodies against parvovirus B19 in Norwegians with congenital coagulation factor defects treated with plasma products from small donor pools.

Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.

Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Documenting hospice care.

After the wood chipper.

Assisted dying and the silencing of medicine's next generation.